Paul Verbesey > Goodwin > Washington DC, United States > Lawyer Profile
Goodwin Offices
901 NEW YORK AVENUE, NW
WASHINGTON DC 20001
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Paul Verbesey
Position
Partner
Career
Paul Verbesey is a partner in the firm’s Private Equity group and former co-chair of the Private Investment Funds practice. Paul focuses his practice on the structuring, formation and operation/ongoing management of a variety of private investment vehicles, including private equity funds, real estate funds, venture capital funds, natural resources funds and securities funds, and their management companies. His corporate practice has also included work in mergers and acquisitions, corporate finance, securities, real estate securities and capital markets and venture capital/private equity. Paul joined Goodwin in 1998.
Education
JD, 1998, William & Mary School of Law / BA, 1992, Georgetown University
Lawyer Rankings
United States > Investment fund formation and management > Private equity funds (including venture capital)
Goodwin‘s ‘top notch’ private investment funds team covers the full spectrum of private investment fund types across various asset classes, where the team has a strong track record with real estate funds, where institutional and high net worth individual investors operating on a national and global level comprise their client base. Mandee Gruen chairs the team and a member of the firm’s real estate industry and ESG and impact practices, with these areas being a focus of her private funds work. Gruen is based in New York, as is John Ferguson, who similarly advises on real estate funds, alongside infrastructure, debt and credit, private equity and fund of funds, while Paul Verbesey is a key name in Washington DC and Matthew Giles and up-and-coming partner Lynette Elam are key names in in Boston. James Donohue left the firm in April 2024.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Capital markets: debt offerings
- International trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade > Customs, export controls and economic sanctions
- Healthcare > Service providers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Shareholder activism